PPIF: A Potential Drug Target and Biomarker for the Treatment of Inflammatory Diseases

Target Name: PPIF

NCBI ID: G10105

PPIF

PPIF: A Potential Drug Target and Biomarker for the Treatment of Inflammatory Diseases

PPIF (pyruvate pathway-intermediary factor) is a protein that plays a crucial role in the intracellular signaling pathway known as the pyruvate pathway. The pyruvate pathway is a central regulatory pathway that involves the metabolism of pyruvate, a critical carbon source for cellular energy production. This pathway is involved in various cellular processes, including cell growth, metabolism, and inflammation. The pyruvate pathway has been implicated in the development and progression of various diseases, including inflammatory diseases.

Inflammatory diseases are a leading cause of morbidity and mortality worldwide, affecting millions of people. These diseases are characterized by chronic inflammation, which can lead to tissue damage, pain, and suffering. The treatment of inflammatory diseases is a major area of research, and there is a growing interest in identifying new targets for these diseases.

PPIF is a potential drug target and biomarker for the treatment of inflammatory diseases. In this article, we will explore the role of PPIF in the development and progression of inflammatory diseases, its potential as a drug target, and its potential as a biomarker for the evaluation of therapeutic interventions.

The Pyruvate Pathway and Inflammatory Diseases

The pyruvate pathway is a complex metabolic pathway that involves the intermediary step of pyruvate, which is converted to acetyl-CoA, a key substrate for the citric acid cycle. The production of pyruvate from glucose is a critical step in the metabolism of energy, and it is involved in the growth, development, and maintenance of all living organisms.

Inflammatory diseases are characterized by chronic inflammation, which can lead to tissue damage, pain, and suffering. These diseases include autoimmune diseases, chronic inflammatory disorders, and certain types of cancer. Chronic inflammation is associated with the production of pro-inflammatory cytokines, which can lead to the recruitment of immune cells, tissue damage, and the progression of disease.

PPIF in the Pyruvate Pathway

PPIF is a protein that plays a crucial role in the intracellular signaling pathway known as the pyruvate pathway. It is a key intermediate step in the production of pyruvate from glucose and has been involved in various cellular processes, including cell growth, metabolism, and inflammation.

PPIF is involved in the regulation of the citric acid cycle. It promotes the conversion of glucose to pyruvate by inhibiting the activity of the enzyme Phosphofructose-1,6-Bisphosphate (Pf1), which is a key enzyme in the citric acid cycle. This inhibition of Pf1 activity allows for the production of pyruvate, which is then converted to acetyl-CoA, a key substrate for the citric acid cycle.

PPIF is also involved in the regulation of cellular signaling pathways, including the TGF-β pathway. TGF-β is a cytokine that plays a role in cell growth, differentiation, and inflammation. PPIF has been shown to regulate the activity of TGF-β by inhibiting the activity of the enzyme transforming growth factor-beta (TG尾), which is a key enzyme in the TGF-β pathway.

PPIF as a Drug Target

The potential use of PPIF as a drug target is based on its involvement in the production of pyruvate, which is a critical substrate for the citric acid cycle and has been implicated in the development and progression of various diseases. Several studies have shown that inhibition of PPIF activity can lead to the inhibition of pro-inflammatory cytokines and improve the symptoms of inflammatory diseases.

One of the potential strategies for the treatment of inflammatory diseases is to target PPIF as

Protein Name: Peptidylprolyl Isomerase F

Functions: PPIase that catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and may therefore assist protein folding (PubMed:20676357). Involved in regulation of the mitochondrial permeability transition pore (mPTP) (PubMed:26387735). It is proposed that its association with the mPTP is masking a binding site for inhibiting inorganic phosphate (Pi) and promotes the open probability of the mPTP leading to apoptosis or necrosis; the requirement of the PPIase activity for this function is debated (PubMed:26387735). In cooperation with mitochondrial p53/TP53 is involved in activating oxidative stress-induced necrosis (PubMed:22726440). Involved in modulation of mitochondrial membrane F(1)F(0) ATP synthase activity and regulation of mitochondrial matrix adenine nucleotide levels (By similarity). Has anti-apoptotic activity independently of mPTP and in cooperation with BCL2 inhibits cytochrome c-dependent apoptosis (PubMed:19228691)

The "PPIF Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PPIF comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets